Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/28/2015 07/29/2015 07/30/2015 07/31/2015 08/03/2015 Date
8.22(c) 7.78(c) 7.85(c) 8.16(c) 8.06(c) Last
4 296 577 11 299 686 3 841 168 8 264 633 3 403 752 Volume
+7.17% -5.35% +0.90% +3.95% -1.23% Change
More quotes
Financials ($)
Sales 2015 145 M
EBIT 2015 -190 M
Net income 2015 -201 M
Finance 2015 43,5 M
Yield 2015 -
Sales 2016 221 M
EBIT 2016 -137 M
Net income 2016 -139 M
Debt 2016 22,1 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 10,2x
EV / Sales 2016 6,99x
Capitalization 1 521 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products includes Iclusig (ponatinib), Brigatinib (previously known as AP26113), and AP32788.The company was founded... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
07/29 ARIAD PHARMACEUTICALS : Entry into a Material Definitive Agreement, Creation of ..
07/29 ARIAD PHARMACEUTICALS : PDL BioPharma Completes Royalty Transaction with ARIAD P..
07/29 ARIAD PHARMACEUTICALS : to Receive up to $200 Million Through Iclusig Non-Diluti..
07/27 ARIAD PHARMACEUTICALS : Other Events (form 8-K)
07/24 ARIAD PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (for..
07/22 ARIAD PHARMACEUTICALS : to Webcast Conference Call on Second Quarter 2015 Financ..
06/24 ARIAD PHARMACEUTICALS : Announces Long-Term Safety and Efficacy Data of Ponatini..
06/22 ARIAD PHARMACEUTICALS : and Paladin Enter into Commercial Distribution Agreement..
More news
Sector news : Biopharmaceuticals
07:40a SHIRE : Says Has Proposed Merger With Baxalta But Talks Refused (ALLISS)
07:36a PFIZER : Enters into Agreement with Synthon
07:31aDJRegeneron Pharmaceuticals Profit Doubles
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/30 PREMARKET BIOTECH DIGEST : Familial Hypercholesterolemia, Dynavax BLA Track, Ear..
07/29 ARIAD Pharma raises up to $200M in capital via synthetic royalty deal with PD..
07/17 PREMARKET BIOTECH DIGEST : Options Trading, Achillion Short Interest, Opdivo EU ..
07/08 $1.5B Ariad Is Smaller But Similar To Pharmacyclics Before The $20B Buyout
06/12 ARIAD's Iclusig delivers long-term therapeutic benefit in blood cancer patien..


Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions